Takeda Pharmaceutical Co. Ltd. and Millennium Pharmaceuticals, Inc. have entered into a definitive agreement under which Takeda will acquire Millennium for approximately $8.8 billion in cash. Upon completion of the acquisition, Millennium will become a wholly-owned subsidiary of Takeda and will continue operations in Cambridge, MA, as a standalone business unit. Millennium will be known as Millennium Pharmaceuticals, Inc., a Takeda Company.     Millennium, a leading biopharmaceutical company,...